Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
Interventions: Drug: BMF-219
Sponsors: Biomea Fusion Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 29, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments